These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19540100)

  • 21. The functional benefit of anti-inflammatory aerosols in the lung periphery.
    Verbanck S; Schuermans D; Paiva M; Vincken W
    J Allergy Clin Immunol; 2006 Aug; 118(2):340-6. PubMed ID: 16890756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhalers and nebulizers in the children].
    David V; Mély L; Siret D; Dubus JC
    Arch Pediatr; 2002 Aug; 9 Suppl 3():415s-421s. PubMed ID: 12205818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation.
    Sebti T; Pilcer G; Van Gansbeke B; Goldman S; Michils A; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2006 Aug; 64(1):26-32. PubMed ID: 16697169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deposition of aerosols in infants and children.
    Schüepp KG; Straub D; Möller A; Wildhaber JH
    J Aerosol Med; 2004; 17(2):153-6. PubMed ID: 15294065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breath-synchronized nebulization diminishes the impact of patient-device interfaces (face mask or mouthpiece) on the inhaled mass of nebulized budesonide.
    Nikander K; Agertoft L; Pedersen S
    J Asthma; 2000 Aug; 37(5):451-9. PubMed ID: 10983623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
    Pitcairn G; Reader S; Pavia D; Newman S
    J Aerosol Med; 2005; 18(3):264-72. PubMed ID: 16181001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
    Cheng YS; Fu CS; Yazzie D; Zhou Y
    J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary drug delivery from the Taifun dry powder inhaler is relatively independent of the patient's inspiratory effort.
    Pitcairn GR; Lankinen T; Seppälä OP; Newman SP
    J Aerosol Med; 2000; 13(2):97-104. PubMed ID: 11010599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effect of nebulized budesonide in asthmatic children.
    Nuhoglu Y; Atas E; Nuhoglu C; Iscan M; Ozcay S
    J Investig Allergol Clin Immunol; 2005; 15(3):197-200. PubMed ID: 16261956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline.
    Ewing P; Eirefelt SJ; Andersson P; Blomgren A; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):169-80. PubMed ID: 18518793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of inhaled steroids on pulmonary epithelial permeability to Tc99m-dTPA in atopic asthmatic children.
    Yuksel H; Yuksel D; Demir E; Tanaç R
    J Investig Allergol Clin Immunol; 2001; 11(3):188-92. PubMed ID: 11831452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of add-on devices for aerosol drug delivery: deposition studies and clinical aspects.
    Newman SP; Newhouse MT
    J Aerosol Med; 1996; 9(1):55-70. PubMed ID: 10160209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aerosol characteristics of admixture of budesonide inhalation suspension with a beta2-agonist, procaterol.
    Itazawa T; Adachi Y; Ito Y; Higuchi O; Mochizuki H; Shimojo N; Inoue T
    Allergol Int; 2013 Mar; 62(1):131-5. PubMed ID: 23348859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing inhaled corticosteroid therapy in children with chronic asthma.
    O'Connell EJ
    Pediatr Pulmonol; 2005 Jan; 39(1):74-83. PubMed ID: 15532098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!
    Amirav I; Balanov I; Gorenberg M; Groshar D; Luder AS
    Arch Dis Child; 2003 Aug; 88(8):719-23. PubMed ID: 12876173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A (99m)Tc-DTPA ventilation study in monitoring the effect of budesonide in asthmatic children.
    Kashyap R; Bhattacharya A; Mathew JL; Parmar M; Mittal BR
    Hell J Nucl Med; 2011; 14(2):121-5. PubMed ID: 21761012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations.
    Zeman KL; Wu J; Bennett WD
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):363-9. PubMed ID: 20863250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
    Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oropharyngeal deposition of 3.5 microns particles inhaled through an elongated mouthpiece.
    Svartengren K; Anderson M; Svartengren M; Philipson K; Camner P
    Eur Respir J; 1996 Jul; 9(7):1556-9. PubMed ID: 8836672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.